Angela M. Sosin, Ph.D. - Publications
Affiliations: | 2012 | Cancer Biology | Wayne State University, Detroit, MI, United States |
Area:
Oncology, Cell Biology, Molecular BiologyYear | Citation | Score | |||
---|---|---|---|---|---|
2014 | Shalhout S, Haddad D, Sosin A, Holland TC, Al-Katib A, Martin A, Bhagwat AS. Genomic uracil homeostasis during normal B cell maturation and loss of this balance during B cell cancer development. Molecular and Cellular Biology. 34: 4019-32. PMID 25154417 DOI: 10.1128/Mcb.00589-14 | 0.584 | |||
2012 | Sosin AM, Burger AM, Siddiqi A, Abrams J, Mohammad RM, Al-Katib AM. HDM2 antagonist MI-219 (spiro-oxindole), but not Nutlin-3 (cis-imidazoline), regulates p53 through enhanced HDM2 autoubiquitination and degradation in human malignant B-cell lymphomas. Journal of Hematology & Oncology. 5: 57. PMID 22989009 DOI: 10.1186/1756-8722-5-57 | 0.658 | |||
2011 | Sosin AM, Yang D, Mohammad RM, Al-Katib A. Abstract 594: MDM2 inhibition by MI-219 elicits differential molecular effects in wild-type p53 lymphoma cells Cancer Research. 71: 594-594. DOI: 10.1158/1538-7445.Am2011-594 | 0.664 | |||
2010 | Al-Katib A, Arnold AA, Aboukameel A, Sosin A, Smith P, Mohamed AN, Beck FW, Mohammad RM. I-kappa-kinase-2 (IKK-2) inhibition potentiates vincristine cytotoxicity in non-Hodgkin's lymphoma. Molecular Cancer. 9: 228. PMID 20809973 DOI: 10.1186/1476-4598-9-228 | 0.61 | |||
2010 | Sosin AM, Burger AM, Yang D, Mohammad RM, Al-Katib A. Abstract 4516: A new class of MDM2 inhibitors cause growth inhibition and stabilize wt p53 in lymphoma cells but do not interfere with MDM2 E3 ligase activity Cancer Research. 70: 4516-4516. DOI: 10.1158/1538-7445.Am10-4516 | 0.651 | |||
2009 | Mohammad RM, Wu J, Azmi AS, Aboukameel A, Sosin A, Wu S, Yang D, Wang S, Al-Katib AM. An MDM2 antagonist (MI-319) restores p53 functions and increases the life span of orally treated follicular lymphoma bearing animals. Molecular Cancer. 8: 115. PMID 19958544 DOI: 10.1186/1476-4598-8-115 | 0.659 | |||
Show low-probability matches. |